NCT06498648 2026-05-13Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue SarcomaNational Cancer Institute (NCI)Phase 1/2 Recruiting74 enrolled